Cargando…
Pharmacovigilance in practice: erythropoiesis-stimulating agents
Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or other problems related to medical products after they have been licensed for marketing. The purpose of PV is to advance the safe use of marketed medical pro...
Autores principales: | Hedenus, Michael, Ludwig, Heinz, Henry, David H, Gasal, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302692/ https://www.ncbi.nlm.nih.gov/pubmed/24890561 http://dx.doi.org/10.1002/cam4.275 |
Ejemplares similares
-
Effects of erythropoiesis-stimulating agents on survival and other outcomes in patients with lymphoproliferative malignancies: a study-level meta-analysis
por: Hedenus, Michael, et al.
Publicado: (2012) -
Patient satisfaction with information on oral anticancer agent use
por: Boons, Christel C. L. M., et al.
Publicado: (2017) -
Early‐life exposures to infectious agents and later cancer development
por: Vedham, Vidya, et al.
Publicado: (2015) -
Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis
por: Filippini, Daria Maria, et al.
Publicado: (2021) -
Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation
por: Hui, Wen, et al.
Publicado: (2018)